This 90-minute webinar is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP) for HIV prevention. We will provide an overview of the recently launched WHO and Jhpiego Provider Training Toolkit on Use of Oral and Long-Acting HIV PrEP, with case-based scenarios to illustrate the key considerations in the clinical management of clients interested in long-acting injectable Lenacapavir (LEN).
Objectives
By the end of the webinar, attendees will clearly understand how to access the training toolkit and what resources are available, as well as gain a foundation for how to manage clients starting and continuing use of Lenacapavir for HIV PrEP.
Date and time
Thursday, 8 October 2025
13:00 – 14:30 CEST
Speakers
- Michelle Rodolph, WHO headquarters
- Heather-Marie Schmidt, UNAIDS
- Elizabeth Irungu, Jhpiego
- Tigistu Adamu Ashengo, Jhpiego
- Katie Journeay, Jhpiego
Webinar series
This is the third webinar in a three-part series:
- Part 1, held on 28 August 2025 provided an overview of the key takeaways and guidance
- Part 2 was held on 4 September 2025 and focused on HIV testing.